0001104659-21-062421.txt : 20210506 0001104659-21-062421.hdr.sgml : 20210506 20210506162528 ACCESSION NUMBER: 0001104659-21-062421 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210504 FILED AS OF DATE: 20210506 DATE AS OF CHANGE: 20210506 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Oxford Sciences Innovation plc CENTRAL INDEX KEY: 0001856079 STATE OF INCORPORATION: X0 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40367 FILM NUMBER: 21898209 BUSINESS ADDRESS: STREET 1: 46 WOODSTOCK ROAD CITY: OXFORD STATE: X0 ZIP: OX2 6HT BUSINESS PHONE: 44(0)7502100076 MAIL ADDRESS: STREET 1: 46 WOODSTOCK ROAD CITY: OXFORD STATE: X0 ZIP: OX2 6HT ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Vaccitech plc CENTRAL INDEX KEY: 0001828185 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: THE SCHRODINGER BUILDING STREET 2: HEATLEY ROAD, THE OXFORD SCIENCE PARK CITY: OXFORD STATE: X0 ZIP: OX4 4GE BUSINESS PHONE: 44 (0) 1865 818808 MAIL ADDRESS: STREET 1: THE SCHRODINGER BUILDING STREET 2: HEATLEY ROAD, THE OXFORD SCIENCE PARK CITY: OXFORD STATE: X0 ZIP: OX4 4GE FORMER COMPANY: FORMER CONFORMED NAME: Vaccitech Ltd DATE OF NAME CHANGE: 20201014 4 1 tm2115262-1_4seq1.xml OWNERSHIP DOCUMENT X0306 4 2021-05-04 0 0001828185 Vaccitech plc VACC 0001856079 Oxford Sciences Innovation plc 46 WOODSTOCK ROAD OXFORD X0 OX2 6HT UNITED KINGDOM 0 0 1 0 Ordinary Shares 2021-05-04 4 C 0 4832142 A 4832142 D Ordinary Shares 2021-05-04 4 C 0 1704444 A 6536586 D Ordinary Shares 2021-05-04 4 C 0 1661184 A 8197770 D American Depositary Shares 2021-05-04 4 P 0 600000 17 A 8797770 D Ordinary Shares 2021-05-04 4 C 0 4832142 D Ordinary Shares 4832142 0 D Series A redeemable convertible preferred shares 2021-05-04 4 C 0 1704444 D Ordinary Shares 1704444 0 D Series B preferred shares 2021-05-04 4 C 0 1661184 D Ordinary Shares 1661184 0 D The Ordinary Shares may be represented by American Depositary Shares, each of whicb currently represents one Ordinary Share. Each American Depositary Share represents one ordinary share. Each ordinary share, Series A redeemable convertible preferred share and Series B preferred share were converted into Ordinary Shares on a one-for-309 basis immediately prior to the closing ofVaccilech plc's (the "Issuer") initial public offering without payment of consideration. None of the ordinary shares, Series A redeemable convertible preferred share and Series B preferred shares had an expiration date. The number of shares reported reflects the conversion set out in Footnote (3). Kate O'Brien, for and on behalf of Oxford Science Innovation plc 2021-05-06